Skip to main content
Market intelligence
MAZESector not reported

Maze Therapeutics, Inc. insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 13, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 13, 2026Harold BernsteinPresident, R&D & CMOSale16,142$27.61$445,621
Aug 3, 2026Jason V ColomaChief Executive OfficerSale34,501$26.73$922,315
Jul 29, 2026Atul DandekarCSBOSale7,500$27.34$205,031